Delivery Order SPE2DE24D0013-SPE2D625F0WGE
- Not listed
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense-affiliated Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc. on May 30, 2025, with an ultimate completion date of June 6, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic systems, specializes in point-of-care testing...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The U.S. Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on July 10, 2025, with an ultimate completion date of July 17, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The Defense Department's Medical Supply Chain awarded a $17,280 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 3, 2025, with completion targeted for September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and procures diagnostic testing solutions, likely reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection based on the contract...
- The Defense Logistics Agency's Medical Supply Chain division awarded an $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer specializing in infectious disease testing solutions. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 12, 2025, is designated as XPCOV2/FLU/RSV-10 and relates to diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV). The...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0WGEDelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded an $8,160 firm fixed-price delivery order to Cepheid Inc. on August 13, 2025, with an ultimate completion date of August 20, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection. The contract carries no set-aside designation and is performed at Cepheid's facility in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, likely fulfills this delivery order under one of its existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, such as the $32.8 million single-award IDV established with VA's Veterans Integrated Service Network 6 through September 30, 2030. The company specializes in providing GeneXpert diagnostic systems and associated reagents across federal healthcare networks, with extensive experience delivering infectious disease testing solutions to the VA, Indian Health Service, and Defense agencies. This award reflects the continued demand for rapid molecular diagnostics within the Defense Health system for routine infectious disease screening and management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/13/25 |